DEXAMETHASONE ACETATE

SynDRA canonical compound SYN0025505 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	NR3C1
Mechanism of action	Glucocorticoid receptor agonist
Indication	allergic rhinitis \| anemia \| dermatitis herpetiformis (DH) \| enteritis \| hypercalcemia \| lupus \| multiple sclerosis \| nephrotic syndrome \| osteoarthritis \| psoriasis \| psoriatic arthritis \| rheumatoid arthritis \| ulcerative colitis
Disease area	allergy \| dermatology \| endocrinology \| gastroenterology \| hematology \| neurology/psychiatry \| rheumatology

All known targets

decadronal
neofordex
Dexamethasone 21-acetate
Dectancyl
Dexamethasone acetate anhydrous
Dexamethasone acetate monohydrate
Dexamethasoni acetas
Dexamethasoni acetas monohydrate
Fortecortin (crystal suspension)
NSC-39471
Decadron-la
Neofordex
dexamethasone
dexamethasone.acetate
Dexamethasone-21-acetate
Decadronal
Decadron-LA
Panasone
Dectan
Dex-Cortidelt acetate
21-O-Acetyl Dexamethasone
CHEBI:4463
MLS000028544
K7V8P532WP
Dexamethasone acetate, anhydrous
CHEMBL1530428
9alpha-Fluoro-16alpha-methylprednisolone acetate
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11beta,16alpha)-
SMR000058327
dexamethason acetate
[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
2-((8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11.beta.,16.alpha.)-
9.alpha.-Fluoro-16.alpha.-methylprednisolone acetate
16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate
9-Fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate
Fortecortin (VAN)